Work

Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study

Year: 2016

Type: article

Study design: Observational Study

Source: Biological Psychiatry

DOI: 10.1016/j.biopsych.2016.02.018

Authors: Zheng Chang, Brian M. D’Onofrio, Patrick D. Quinn, Paul Lichtenstein, Henrik Larsson

Institutions: Karolinska Institutet, Indiana University Bloomington, Indiana University, Örebro University

Language: English

Topic: Attention Deficit Hyperactivity Disorder

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Vetenskapsrådet, National Institutes of Health, National Institute of Mental Health, National Center for Advancing Translational Sciences

Awards: Indiana Clinical and Translational Sciences Institute, Risks and Benefits of ADHD Medication for Psychiatric and Neurologic Problems, Indiana Clinical and Translational Sciences Institute

OpenAlex ID: W2278520419

FWCI: 10.66

Cites: 39

Cited by: 152

Related to: 10